Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
about
Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional StudyFracture rate in patients with myasthenia gravis: the general practice research database.Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.Negative impact of high cumulative glucocorticoid dose on bone metabolism of patients with myasthenia gravis.
P2860
Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
@en
Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
@nl
type
label
Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
@en
Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
@nl
prefLabel
Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
@en
Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
@nl
P2093
P1476
Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
@en
P2093
Atushi Nakazato
Hideki Sugimoto
Hiroshi Nemoto
Nobuatu Nomoto
Nobuo Wakata
Norihide Hayashi
Shingo Konno
P304
P356
10.1016/J.CLINEURO.2003.12.001
P577
2004-03-01T00:00:00Z